Published in Am J Clin Dermatol on January 01, 2007
A comparison of epithelial-to-mesenchymal transition and re-epithelialization. Semin Cancer Biol (2012) 1.00
The expression of sphingosine kinase-1 in head and neck carcinoma. Cells Tissues Organs (2010) 0.95
Cancer and multiple sclerosis in the era of disease-modifying treatments. J Neurol (2011) 0.94
Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. Br J Pharmacol (2011) 0.90
Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis. J Biol Chem (2013) 0.83
Distribution of bioactive lipid mediators in human skin. J Invest Dermatol (2015) 0.81
Analysis of ceramide metabolites in differentiating epidermal keratinocytes treated with calcium or vitamin C. Nutr Res Pract (2011) 0.79
Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate. PLoS One (2014) 0.77
Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment. Sci Rep (2015) 0.77
Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans. Mediators Inflamm (2015) 0.75
Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients. Arch Dermatol Res (2016) 0.75
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest (2004) 2.36
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest (2013) 2.08
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest (2007) 1.67
Human defensins. J Mol Med (Berl) (2005) 1.66
Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J Invest Dermatol (2009) 1.60
Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J Invest Dermatol (2003) 1.59
Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. J Biol Chem (2004) 1.48
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med (2013) 1.36
Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol (2004) 1.29
The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats. Acta Derm Venereol (2012) 1.21
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol (2007) 1.17
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging (2006) 1.17
Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. J Drugs Dermatol (2011) 1.17
Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. Microb Pathog (2002) 1.15
Toll-like receptors and innate antifungal responses. Trends Microbiol (2004) 1.14
Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol (2009) 1.13
Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J Mol Med (Berl) (2009) 1.06
Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother (2003) 1.06
Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem (2004) 1.06
Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet (2010) 1.05
The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death. Br J Pharmacol (2014) 1.01
Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm (2008) 0.99
Onychodystrophy and its management. Ger Med Sci (2003) 0.97
Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology (2005) 0.97
Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol (2005) 0.97
Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications. J Dtsch Dermatol Ges (2010) 0.96
Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J Invest Dermatol (2008) 0.95
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX (2014) 0.94
Chitin modulates innate immune responses of keratinocytes. PLoS One (2011) 0.93
Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents (2010) 0.92
[Cellulite--the greatest skin problem in healthy people? An approach]. J Dtsch Dermatol Ges (2006) 0.92
Different skin thinning potential of equipotent medium-strength glucocorticoids. Skin Pharmacol Appl Skin Physiol (2002) 0.90
Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. J Invest Dermatol (2008) 0.89
Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. Cell Signal (2004) 0.88
3D-wound healing model: influence of morphine and solid lipid nanoparticles. J Biotechnol (2010) 0.88
The role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection and autoimmune diseases. Curr Opin Investig Drugs (2009) 0.88
Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int J Pharm (2009) 0.87
X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans. Proteins (2008) 0.87
Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis. J Invest Dermatol (2004) 0.87
Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis. Am J Clin Dermatol (2007) 0.87
Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. J Antimicrob Chemother (2005) 0.86
The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology. Arch Immunol Ther Exp (Warsz) (2006) 0.86
Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. Diabetologia (2013) 0.86
Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management. J Dtsch Dermatol Ges (2006) 0.86
Lactobacilli - bacteria-host interactions with special regard to the urogenital tract. Int J Med Microbiol (2005) 0.86
Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Altern Lab Anim (2011) 0.85
Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells. Tumour Biol (2010) 0.85
17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression. Eur J Pharmacol (2006) 0.85
SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions. Int J Pharm (2010) 0.85
The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. Altern Lab Anim (2008) 0.84
Antiapoptotic action of 1alpha,25-dihydroxyvitamin D3 in primary human melanocytes. Melanoma Res (2003) 0.84
A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds. Int J Pharm (2013) 0.84
Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin. Exp Dermatol (2014) 0.84
Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages. PLoS One (2010) 0.83
Glucocorticoid receptor interactions with glucocorticoids: evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants. Steroids (2003) 0.83
Receptor-selective retinoids for psoriasis: focus on tazarotene. Am J Clin Dermatol (2006) 0.83
Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. PLoS One (2012) 0.83
Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J Dermatol Sci (2013) 0.83
The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A. Proteins (2007) 0.83
Novel methods for the quantification of (2E)-hexadecenal by liquid chromatography with detection by either ESI QTOF tandem mass spectrometry or fluorescence measurement. Anal Chim Acta (2012) 0.83
Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res (2007) 0.83
Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells. PLoS One (2012) 0.83
Sphingosine 1-phosphate mediates chemotaxis of human primary fibroblasts via the S1P-receptor subtypes S1P₁ and S1P₃ and Smad-signalling. Cytoskeleton (Hoboken) (2010) 0.82
Divergent role of sphingosine 1-phosphate on insulin resistance. Cell Physiol Biochem (2014) 0.82
Sphingosine-1-phosphate modulates dendritic cell function: focus on non-migratory effects in vitro and in vivo. Cell Physiol Biochem (2014) 0.82
Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. J Invest Dermatol (2010) 0.82
Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation. PLoS One (2012) 0.82
The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med (Berl) (2011) 0.82
Effective inhibition of acid and neutral ceramidases by novel B-13 and LCL-464 analogues. Bioorg Med Chem (2012) 0.82
Onychomycosis. J Dtsch Dermatol Ges (2007) 0.82
Ultrasensitive detection of unknown colon cancer-initiating mutations using the example of the Adenomatous polyposis coli gene. Cancer Prev Res (Phila) (2013) 0.81
Structural aspects of histone H1-DNA complexes and their relation to transfection efficiency. Biotechnol Appl Biochem (2005) 0.81
The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. Liver Int (2013) 0.81
Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation. Altern Lab Anim (2008) 0.80
Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate. Eur J Pharm Biopharm (2012) 0.80
Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment? Drugs (2005) 0.80
Improved differentiation of benign and malignant lymphadenopathy in patients with cutaneous melanoma by contrast-enhanced color Doppler sonography. Arch Dermatol (2002) 0.80
Evaluation of anti-inflammatory and atrophogenic effects of glucocorticoids on reconstructed human skin. Altern Lab Anim (2011) 0.80
In vitro models for human skin disease. Drug Discov Today (2010) 0.80
Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation. Cell Physiol Biochem (2010) 0.79
Bilateral areolar and periareolar pityriasis versicolor. J Dtsch Dermatol Ges (2010) 0.79
[Oral candidiasis]. J Dtsch Dermatol Ges (2008) 0.79
Dexamethasone protects human fibroblasts from apoptosis via an S1P3-receptor subtype dependent activation of PKB/Akt and Bcl XL. Pharmacol Res (2009) 0.79
Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. Cardiovasc Res (2013) 0.79